1. Home
  2. SMID vs CMPX Comparison

SMID vs CMPX Comparison

Compare SMID & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • CMPX
  • Stock Information
  • Founded
  • SMID 1960
  • CMPX 2014
  • Country
  • SMID United States
  • CMPX United States
  • Employees
  • SMID N/A
  • CMPX N/A
  • Industry
  • SMID Building Materials
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMID Industrials
  • CMPX Health Care
  • Exchange
  • SMID Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • SMID 157.4M
  • CMPX 291.8M
  • IPO Year
  • SMID 1995
  • CMPX N/A
  • Fundamental
  • Price
  • SMID $34.50
  • CMPX $2.66
  • Analyst Decision
  • SMID
  • CMPX Strong Buy
  • Analyst Count
  • SMID 0
  • CMPX 9
  • Target Price
  • SMID N/A
  • CMPX $12.67
  • AVG Volume (30 Days)
  • SMID 20.9K
  • CMPX 826.0K
  • Earning Date
  • SMID 08-13-2025
  • CMPX 08-11-2025
  • Dividend Yield
  • SMID N/A
  • CMPX N/A
  • EPS Growth
  • SMID 866.67
  • CMPX N/A
  • EPS
  • SMID 1.45
  • CMPX N/A
  • Revenue
  • SMID $78,508,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • SMID N/A
  • CMPX N/A
  • Revenue Next Year
  • SMID N/A
  • CMPX N/A
  • P/E Ratio
  • SMID $22.79
  • CMPX N/A
  • Revenue Growth
  • SMID 31.77
  • CMPX N/A
  • 52 Week Low
  • SMID $25.03
  • CMPX $0.82
  • 52 Week High
  • SMID $51.96
  • CMPX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • SMID 61.58
  • CMPX 62.29
  • Support Level
  • SMID $32.85
  • CMPX $2.62
  • Resistance Level
  • SMID $35.37
  • CMPX $2.87
  • Average True Range (ATR)
  • SMID 1.51
  • CMPX 0.17
  • MACD
  • SMID 0.33
  • CMPX -0.00
  • Stochastic Oscillator
  • SMID 86.51
  • CMPX 75.36

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: